Hirama M - Search Results

1

ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.

Tajima K, Hirama M, Shiomi K, Ishiwata T, Yoshioka M, Iwase A, Iwakami S, Yamazaki M, Toba M, Tobino K, Sugano K, Ichikawa M, Hagiwara Y, Takahashi K, Hino O. Tajima K, et al. Among authors: hirama m. Anticancer Res. 2008 Nov-Dec;28(6B):3933-6. Anticancer Res. 2008. PMID: 19192652 Free article.

2

The N-ERC index is a novel monitoring and prognostic marker for advanced malignant pleural mesothelioma.

Mori T, Tajima K, Hirama M, Sato T, Kido K, Iwakami S, Sasaki S, Iwase A, Shiomi K, Maeda M, Hino O, Takahashi K. Mori T, et al. Among authors: hirama m. J Thorac Dis. 2013 Apr;5(2):145-8. doi: 10.3978/j.issn.2072-1439.2013.03.03. J Thorac Dis. 2013. PMID: 23585940 Free PMC article.

3

Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.

Cui R, Takahashi F, Ohashi R, Yoshioka M, Gu T, Tajima K, Unnoura T, Iwakami S, Hirama M, Ishiwata T, Iwase A, Takahashi K. Cui R, et al. Among authors: hirama m. Lung Cancer. 2009 Mar;63(3):368-74. doi: 10.1016/j.lungcan.2008.06.020. Epub 2008 Aug 26. Lung Cancer. 2009. PMID: 18752867

4

A feasibility study of zoledronic acid combined with carboplatin/nedaplatin plus paclitaxel in patients with non-small cell lung cancer with bone metastases.

Ishiwata T, Hirose T, Hirama M, Miura K, Iwakami S, Tominaga S, Adachi M, Takahashi K. Ishiwata T, et al. Among authors: hirama m. Tumori. 2011 Sep-Oct;97(5):568-72. doi: 10.1177/030089161109700505. Tumori. 2011. PMID: 22158485

5

Lymphangioleiomyomatosis diagnosed by immunocytochemical and genetic analysis of lymphangioleiomyomatosis cell clusters found in chylous pleural effusion.

Hirama M, Atsuta R, Mitani K, Kumasaka T, Gunji Y, Sasaki S, Iwase A, Takahashi K, Seyama K. Hirama M, et al. Intern Med. 2007;46(18):1593-6. doi: 10.2169/internalmedicine.46.0225. Epub 2007 Sep 14. Intern Med. 2007. PMID: 17878649 Free article.

6

[Efficacy of gefitinib according to smoking status in non-small cell lung cancer patients].

Shukuya T, Hirama M, Yae T, Miyaji A, Ishiwata T, Miura K, Seyama K, Takahashi K. Shukuya T, et al. Among authors: hirama m. Gan To Kagaku Ryoho. 2008 Dec;35(13):2367-71. Gan To Kagaku Ryoho. 2008. PMID: 19098404 Japanese.

7

[A case of primary squamous cell carcinoma of the lung with a metastatic thyroid tumor improved following chemotherapy].

Hirama M, Takahashi K, Takagi Y, Ohhashi R, Suzuki K, Sato K, Seyama K, Uekusa T, Fukuchi Y. Hirama M, et al. Nihon Kokyuki Gakkai Zasshi. 2004 Jan;42(1):94-8. Nihon Kokyuki Gakkai Zasshi. 2004. PMID: 14768372 Review. Japanese.

8

[Twelve cases of advanced thymic carcinoma: a clinical review].

Kuriyama S, Ohashi R, Matsuda K, Sugano K, Muraki K, Minakata K, Ishiwata T, Hirama M, Kodama Y, Oh S, Suzuki K, Takahashi K. Kuriyama S, et al. Among authors: hirama m. Nihon Kokyuki Gakkai Zasshi. 2010 Aug;48(8):604-8. Nihon Kokyuki Gakkai Zasshi. 2010. PMID: 20803979 Japanese.

9

Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity.

Takahashi K, Takahashi F, Hirama M, Tanabe KK, Fukuchi Y. Takahashi K, et al. Among authors: hirama m. Lung Cancer. 2003 Aug;41(2):145-53. doi: 10.1016/s0169-5002(03)00224-1. Lung Cancer. 2003. PMID: 12871777

10

Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth.

Hirama M, Takahashi F, Takahashi K, Akutagawa S, Shimizu K, Soma S, Shimanuki Y, Nishio K, Fukuchi Y. Hirama M, et al. Cancer Lett. 2003 Jul 30;198(1):107-17. doi: 10.1016/s0304-3835(03)00286-6. Cancer Lett. 2003. PMID: 12893437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters